Health Care

GW Pharmaceuticals Plc (NASDAQ:GWPH) expecting to achieve $125.52 in next 52-weeks

0 31

Shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) climbed +23.55% and ended at $104.03 greater than previous closing price of $84.20. The total 3.12 million shares were bought and sold throughout the most recent trading session more than average volume of 523.86 thousand shares.

GW Pharmaceuticals Plc (GWPH):

Currently GW Pharmaceuticals Plc (GWPH) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “5″ Analysts”. “1” rated “Sell” for the company. “1” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $125.52 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $165.00 however minimum price target advised by analysts is $40.00. The Median price target for the stock is measured at $147.00.

Presently, Analysts decided consensus EPS estimate of $-1.40 for present quarter and one month ago projected EPS estimate was at $-1.42. If we take a look at back 3 month ago, consensus EPS estimate was $-1.73.

A current consensus EPS estimate for next quarter is at $-1.40 and 3 month ago EPS forecast was $-1.73. Have a look at back 1 month ago, consensus EPS forecast was seen at $-1.42.

For current fiscal year, most recent EPS estimate is set at $-4.27 based on Analyst consensus and three month ago consensus EPS opinions was at $-5.72. During period one month ago, consensus EPS forecast was decided at $-5.01.

A current consensus EPS projection for next fiscal year is observed at $-5.64 and one month ago consensus EPS forecast was at $-5.29. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-7.16 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 5 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 0 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 6 said a “Buy Rating” and 0 announced “Overweight Rating”. 0 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.


About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.